$107.14
arrow_drop_down1.15%Key Stats | |
---|---|
Open | $108.30 |
Prev. Close | $108.39 |
EPS | 5.89 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
LOW | HIGH | |
---|---|---|
Day Range | 105.99 | 108.78 |
52 Week Range | 99.06 | 139.22 |
Ratios | |
---|---|
EPS | 5.89 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices
VEON’s Jazz Secures Pakistan’s Largest Long-Term Private Sector Syndicated Credit Facility of up to PKR 75 billion - GlobeNewswire
Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024 - GlobeNewswire
UBS cuts Jazz Pharmaceuticals target to $113 from $117 By Investing.com - Investing.com
Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
JAZZ Falls as Suvecaltamide Tremor Study Fails to Meet Goals